Congratulations to UTMB MS4 Christopher Thang for his recent publication in the Journal of Allergy and Clinical Immunology: In Practice (Impact Factor 6.6), which found that dupilumab treatment in atopic dermatitis patients was associated with a progressive reduction in the incidence rate of alopecia areata.
Reference:
Levine, J, Tang, A, O'Hagan, R, Mo, L, Islam, RK, Thang, CJ, Gulati, N, Talia, J, Guttman-Yassky, E, & Ungar, B. (2026). Dupilumab treatment for atopic dermatitis associated with reduced risk of alopecia areata: A multicenter cohort study. The journal of allergy and clinical immunology. In practice, S2213-2198(26)00219-9. Advance online publication. https://doi.org/10.1016/j.jaip.2026.03.015